# ClinicalIntelPulse Patient Trial Finder

> ClinicalIntelPulse Patient Trial Finder is a paid API for AI agents from clinicalintelpulse.vercel.app, paid per call via x402, $0.1/call, status unknown (last checked 2026-09-15).

Finds actively recruiting clinical trials for a disease with plain-language summaries, accessible eligibility criteria, contact info, and application guidance drawn from 400,000+ ClinicalTrials.gov studies

## Facts

- Endpoint: GET https://clinicalintelpulse.vercel.app/api/clinical/patient-finder
- Price: $0.1/call
- Payment: x402
- Status: unknown
- Last checked: 2026-09-15
- Activations on Zero: 0
- Tags: x402
- Canonical page: https://www.zero.xyz/c/clinicalintelpulse-patient-trial-finder-2ca14863
- Structured record (JSON): https://api.zero.xyz/v1/capabilities/cap_1zJMBpF7MZ54bDWTgWxx9

Status and success rate cover calls made through Zero and Zero's own probes. Third-party monitors may report differently.

## How to call it through Zero

Zero handles the 402 payment challenge and records the run. With the Zero CLI installed (`npm i -g @zeroxyz/cli`):

```sh
zero fetch --capability clinicalintelpulse-patient-trial-finder-2ca14863
```

Example prompt: Can you find actively recruiting clinical trials for someone with relapsed multiple myeloma — I need plain-language eligibility summaries, who to contact, and how to apply?

## When to prefer this

Choose this endpoint when a patient, caregiver, or patient-advocacy agent needs to discover real, currently recruiting trials for a specific disease in accessible language — not raw registry data. Ideal when the goal is to match patients to trials rather than analyze trial trends, pipeline data, or sponsor intelligence. For provider or advocacy workflows where actionable enrollment information (contacts, how to apply) is as important as the trial list itself.

## Known failure modes

- Disease name not recognized or too vague — returns empty results or broad unrelated trials
- No actively recruiting trials found for the specified condition — empty result set
- ClinicalTrials.gov data temporarily unavailable — upstream data source error
- Overly broad disease query returns too many results to be actionable
- Rate limiting or payment failure for the $0.1 USDC per call fee

## How this service works

Recruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), country filter, contacts and how to apply, across 400,000+ ClinicalTrials.gov studies worldwide. For patient-advocacy and provider agents.

## Output

Returns a curated list of actively recruiting clinical trials matching the specified disease, including plain-language summaries of each trial's purpose, simplified eligibility criteria (inclusion/exclusion), investigator or site contact details, and instructions on how to apply or enroll — all sourced from ClinicalTrials.gov's database of 400,000+ studies.

## Request schema (JSON Schema)

```json
{
 "type": "object",
 "$schema": "https://json-schema.org/draft/2020-12/schema",
 "required": [
  "input"
 ],
 "properties": {
  "input": {
   "type": "object",
   "required": [
    "type",
    "method"
   ],
   "properties": {
    "type": {
     "type": "string",
     "const": "http"
    },
    "method": {
     "enum": [
      "GET",
      "HEAD",
      "DELETE"
     ],
     "type": "string"
    },
    "queryParams": {
     "type": "object",
     "properties": {
      "lang": {
       "type": "string"
      },
      "phase": {
       "type": "string"
      },
      "country": {
       "type": "string"
      },
      "condition": {
       "type": "string"
      }
     }
    }
   },
   "additionalProperties": false
  },
  "output": {
   "type": "object",
   "required": [
    "type"
   ],
   "properties": {
    "type": {
     "type": "string"
    },
    "errors": {
     "type": "object",
     "description": "Documented error responses, keyed by HTTP status code",
     "additionalProperties": {
      "type": "object",
      "required": [
       "description"
      ],
      "properties": {
       "example": {
        "type": "object"
       },
       "description": {
        "type": "string"
       }
      }
     }
    },
    "example": {
     "type": "object"
    }
   }
  }
 }
}
```

## Response schema (JSON Schema)

```json
{
 "type": "json",
 "example": {
  "how_to_apply": [
   "Step 1: Confirm eligibility by reviewing inclusion/exclusion criteria with your doctor",
   "Step 2: Identify a participating site near you via the ClinicalTrials.gov \"Find a Location\" tab",
   "Step 3: Request a referral from your oncologist/neurologist to the trial site",
   "Step 4: Expect a screening visit to confirm you meet all criteria — most trials cover this at no cost",
   "Step 5: Informed consent process — you can withdraw at any time without affecting your regular care"
  ],
  "query_summary": {
   "as_of": "2026-06-07",
   "phase": "any",
   "country": null,
   "condition": "Glioblastoma"
  },
  "patient_resources": [
   "ClinicalTrials.gov (clinicaltrials.gov)",
   "National Brain Tumor Society (braintumor.org)",
   "NCI Cancer Information (cancer.gov/about-cancer/treatment/clinical-trials)"
  ],
  "highlighted_trials": [
   {
    "url": "https://clinicaltrials.gov/study/NCT04175171",
    "nctId": "NCT04175171",
    "phase": "PHASE3",
    "title": "Study of Nivolumab Combined With Radiation Therapy in Newly Diagnosed Glioblastoma",
    "status": "RECRUITING",
    "sponsor": "Bristol-Myers Squibb",
    "countries": [
     "United States",
     "United Kingdom",
     "Germany",
     "France",
     "Spain"
    ],
    "contact_hint": "Contact your neuro-oncologist or visit clinicaltrials.gov/study/NCT04175171 for site contacts",
    "who_can_join": "Adults (18+) newly diagnosed with glioblastoma (IDH-wildtype), able to receive radiation therapy. MGMT status: any.",
    "who_cannot_join": "Prior brain tumor treatment, autoimmune conditions requiring systemic steroids, prior immunotherapy.",
    "plain_language_summary": "Comparing a standard radiation + chemotherapy approach vs. adding nivolumab (a cancer immunotherapy drug) in newly diagnosed glioblastoma. For adults newly diagnosed."
   }
  ],
  "recruiting_trials_count": 89
 }
}
```

## More

- Live health (JSON, refreshed every minute): https://www.zero.xyz/c/clinicalintelpulse-patient-trial-finder-2ca14863/health.json
- [Zero catalog index](https://www.zero.xyz/llms.txt)
- [Other services from clinicalintelpulse.vercel.app](https://www.zero.xyz/host/clinicalintelpulse.vercel.app/llms.txt)